The breakout may not continue to consolidate to the side apex before breaking up. Those who are keen to participate in the Healthcare sector may want to do more research on this counter before going long.
Please DYODD
NYSE:ELV had a great earnings, beating on top and bottom line estimates and following through with a 10% dividend increase. This comes as NYSE:UNH and NYSE:HUM each disappoint and lower guidance.
ELV has put in a strong consolidation after retracing from 2022 highs. Using a fib fan from the 2022 all time high to the April 2023 high, and another from the...
Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.
Year-long base/consolidation looking ready to break to the upside.
Hi traders,
let's have a look at the ELV chart.
The trend overall looks bullish, however the price is now at the resistance.
We are expecting the breakout. If the breakout occurs, we can take long position.
The target would be at 550$.
Good risk / reward ratio on this trade.
Ascending Triangle.
- Target Entry: $485.50
- Stop Loss: $474.67
- Target Exit Conservative: $520.50
- Target Exit Aggressive: $545.52
- Risk / Reward Ratio: 3.23 / 5.54
About me
- Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be...
NYSE:ELV
If the stock price manages to surpass the bullish line, which is positioned around $469.79, the main target on the bullish side to monitor would be Target Price 1 at $480.96.
On the other hand, if the stock price breaks below the bearish line, set at $458.39, there are several potential downside targets. The first target on the bearish side would be...
Analyzing the options chain and the chart patterns of ELV Elevance Health prior to the earnings report this week,
I would consider purchasing the 450usd strike price Puts with
an expiration date of 2023-10-20,
for a premium of approximately $4.95.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking...
Elevance Health Inc. (ELV) approaching significant overhead resistance, able to absorb monthly buying pressures.
From here, (ELV) can reject and fall lower to channel support, eliciting losses of 15% - 20% over the following 2 - 3 months.
Inversely, a weekly settlement above resistance would place (ELV) into a buy-signal where gains of 15% - 20% would be...
After a multi Decades long run and massive unemployment goals needing met for economic stability, the healthcare sector finally looks to be in trouble...
ELV (formerly Anthem Healthcare)
Bottom to bottom cycles running around 15 bars, or 105 days. Up cycle running approximately 5 bars or 33 days for 77 to 79 points.
Strategy:
ELV is under declining 52 week EMA, and under the Ichy cloud. Nevertheless, excellent fundamentals make this a good swing candidate convertible to a potential long hold.
I would hope for...
The PEAD projected a bullish outlook for NYSE:ELV after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
Elevance Health NYSE:ELV - Long term positioning
Positive earnings are causing a pump in price but be careful here though. Earnings positive since April 2020, why the pump? If i was entering a long term position here i would be waiting for the bottom of the parallel channel and RSI resistance line or at least harboring some cash on the side and splitting my...
The PEAD projected a neutral outlook for NYSE:ELV after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 50%.
The PEAD projected a Bullish outlook for $ELV after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 63.64%.
The PEAD projected a Bullish outlook for $ELV after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 60%.
The PEAD projected a Neutral outlook for $ELV after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
